Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 22.22 USD -2.42% Market Closed
Market Cap: 2B USD
Have any thoughts about
Myriad Genetics Inc?
Write Note

Myriad Genetics Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Myriad Genetics Inc
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Myriad Genetics Inc
NASDAQ:MYGN
Total Liabilities
$344.6m
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
13%
Abbvie Inc
NYSE:ABBV
Total Liabilities
$135.2B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$35.3B
CAGR 3-Years
-10%
CAGR 5-Years
-3%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$85B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$5.4B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
19%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$7.9B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
22%

See Also

What is Myriad Genetics Inc's Total Liabilities?
Total Liabilities
344.6m USD

Based on the financial report for Jun 30, 2024, Myriad Genetics Inc's Total Liabilities amounts to 344.6m USD.

What is Myriad Genetics Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
13%

Over the last year, the Total Liabilities growth was -24%. The average annual Total Liabilities growth rates for Myriad Genetics Inc have been -9% over the past three years , -6% over the past five years , and 13% over the past ten years .

Back to Top